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Altered Penetration of Polyethylene Glycols into
Uninvolved Skin of Atopic Dermatitis Patients
Ivone Jakasa1, Maarten M. Verberk1, Maria Esposito2, Jan D. Bos3 and Sanja Kezic1
Involved regions of the skin in atopic dermatitis (AD) patients have an altered barrier function. Whether
uninvolved skin also has a diminished barrier is controversial. To assess the barrier function of uninvolved skin
in AD patients, the percutaneous penetration of polyethylene glycols (PEGs) of various molecular sizes was
determined in vivo in AD patients and control subjects using tape stripping of the stratum corneum (SC). The
diffusion and partition coefficients were determined using Fick’s second law of diffusion. The SC thickness was
similar in both groups; however, the trans-epidermal water loss was higher in atopic skin. The apparent
diffusion coefficient of PEGs through atopic skin was twice as high as through normal skin, and decreased with
increasing molecular weight (MW) in both groups. The partition coefficient in the skin of AD patients was half
of that for normal skin but as for normal skin, there was no MW dependency. Although atopic skin exhibited
altered barrier with respect to diffusion and partitioning, the permeability coefficients were nearly the same for
atopic and normal skin. The results support the assumption of altered skin barrier of AD patients even in the
skin that is visibly unaffected by disease.
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INTRODUCTION
The affected skin of patients with atopic dermatitis (AD) is
known to have a defective barrier function. The alteration in
the skin barrier in vivo is shown by the increase in trans-
epidermal water loss (TEWL), in other words a poorer barrier
to water transport (Seidenari and Giusti, 1995). On the other
hand, the data on the permeability of uninvolved AD skin are
contradictory. Some authors have reported higher TEWL in
vivo in patients with AD history (Werner and Lindberg, 1985;
Agner, 1990; Berardesca et al., 1990; Watanabe et al., 1991;
Seidenari and Giusti, 1995; Di Nardo et al., 1998; Tabata
et al., 1998), whereas others found no difference in
comparison to normal skin (Seidenari, 1994; Tanaka et al.,
1997; Basketter et al., 1998; Di Nardo et al., 1998; Nicander
and Ollmar, 2004). The well-known higher susceptibility to
irritation in AD patients (Seidenari, 1994; Goffin and Pierard,
1996; Tabata et al., 1998; Nicander and Ollmar, 2004) might
be partly explained by higher skin permeability (de Jongh
et al., 2006). Increased penetration of theophylline in both
involved and uninvolved AD skin in vitro was reported
(Yoshiike et al., 1993). In our previous in vivo study, the
percutaneous penetration of sodium lauryl sulfate was altered
in uninvolved skin of AD patients (Jakasa et al., 2006).
Impaired skin barrier in AD has often been linked to the
different lipid composition and structure of atopic stratum
corneum (SC) in both involved as well as in uninvolved SC of
AD patients (Imokawa et al., 1991; Yamamoto et al., 1991;
Di Nardo et al., 1998; Bleck et al., 1999).
The trans-dermal permeability of many chemicals has
been described using a model based on the octanol–water
partition coefficient (Ko/w) and molecular weight (MW) of the
chemical (Kasting et al., 1987; Potts and Guy, 1992), showing
exponential decrease of diffusion as a function of MW. Based
on clinical experience, it was proposed that the absorption of
molecules through normal human skin declines rapidly as
MW increases over 500 Da (Bos and Meinardi, 2000). As
regards to the role of MW in penetration through compro-
mised skin in vivo, direct evidence is lacking.
This in vivo study investigated the skin penetration of
polyethylene glycols (PEGs) of different MWs (150–590 Da)
into uninvolved skin of AD patients compared to control
subjects using tape stripping of the SC and the approach
based on Fick’s second law of diffusion for non-steady state
condition (Pirot et al., 1997). PEG is a hydrophilic polymer
widely used in corneal and intestinal permeability research.
The octanol/water partition coefficient (log Ko/w B 1.6)
does not change greatly with molecular size which makes
PEGs, suitable model compounds that are not confounded
by change in lipophilicity with molecular size (Hollander
et al., 1989).
See related commentary on pg 8
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RESULTS
To remove the SC completely, 2875 strips were needed on
average for control subjects and 2877 for AD patients.
Before exposure, TEWL was higher in the AD patients
(8.474.3 g m2 hour1) than the control subjects (6.37
2.1 g m2 hour1, Po0.05). After the removal of exposure
chamber containing PEG mixture, TEWL was 6.372.8 and
6.073.5 g m2 hour1 for AD patients and control subjects,
respectively. We found no significant difference in the SC
thickness between the two groups (8.772.5 and 9.471.9mm
for control subjects and AD patients, respectively).
Figure 1 shows a typical concentration profile for PEG282
and PEG590 across SC in a control subject and an AD patient
together with the fitted curve which presents the solution to
the Fick’s second law of diffusion for non-steady state
condition (dashed lines). The curve fitting could be
performed for all control subjects and AD patients
(r240.95), except for PEG150. For PEG150, in four AD
patients, a linear relationship was found between the
concentration and SC depth, indicating steady-state absorp-
tion to which Fick’s second law of diffusion cannot be used to
derive diffusion coefficient. Further, in two control subjects,
curve fitting could not be performed for PEG150 because of
excessive variability of data points.
The results are summarized in Table 1. The apparent
diffusion coefficient decreases with increasing MW of the
penetrant. It was approximately twice as high for all PEGs in
the AD patients as in the control subjects, except for PEG150,
where it was only 60% higher in the AD patients (Po0.0001
for all PEGs). We also compared the control subjects and the
AD patients according to state of disease: patients with active
and inactive AD. As the result of one-way analysis of variance
test for diffusion coefficient was significant (Po0.05),
Bonferroni post hoc analyses were performed. The mean
value of diffusion coefficient in patients with active AD was
significantly higher than in the control subjects for all PEG
molecules (Po0.05 for all PEGs). No significant difference
was found between patients with inactive AD and the control
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Figure 1. Concentration decay of PEG282 and PEG590 as a function of normalized position (x/L) in the SC in one control subject and one AD patient
after 6 hours exposure to PEG mixture. Non-linear regression analysis was used to fit the equation (Equation 1) to the experimentally obtained data (dashed
lines). The apparent diffusion coefficient is calculated from D/L2 value determined from the slope of the curve, whereas the partition coefficient is determined
from KCveh at the intercept at x¼ 0.
Table 1. Penetration parameters of PEGs for AD patients and control subjects
D109 (cm2 h1)** D/L2103 (h1)* K** Kp105 (cm h1)#
MW (Da) AD Ctrl AD Ctrl AD Ctrl AD Ctrl
150 13.376.7 8.475.2 15.977.4 10.876.6 1.0270.29 1.6670.70 1.3470.42 1.2570.39
282 9.275.1 4.572.9 11.578.4 5.673.0 0.9370.38 1.7671.00 0.8470.55 0.6870.24
326 8.274.2 4.572.8 9.975.2 5.572.9 0.8670.35 1.7270.99 0.6970.30 0.6670.25
370 7.673.8 4.172.7 9.274.7 4.972.7 0.8670.37 1.7470.96 0.6570.40 0.6070.22
414 6.773.6 3.572.2 7.773.4 4.272.0 0.8570.37 1.7870.94 0.5470.19 0.5570.21
458 6.273.2 3.271.9 7.173.2 3.971.8 0.8270.38 1.7870.92 0.4870.22 0.5170.19
502 6.173.0 2.971.7 7.173.3 3.671.6 0.8170.38 1.7870.85 0.4970.27 0.4870.19
546 5.073.0 2.471.4 5.873.5 3.071.4 0.8070.43 1.8770.78 0.3770.23 0.4470.19
590 3.872.8 1.971.1 4.573.5 2.471.2 0.9670.53 1.8570.82 0.3470.27 0.3570.19
AD, atopic dermatitis patients (mean7standard deviation, n=20); Ctrl, control subjects (mean7SD, n=20); D, apparent diffusion coefficient; D/L2, diffusion
rate constant; K, stratum corneum/water partition coefficient; Kp, permeability coefficient; MW, molecular weight; PEG, polyethylene glycol.
**Po0.0001, *P=0.0001–0.02, and #P40.1 (for all PEG oligomers, one-tailed t-test).
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subjects, or between AD patients with active and inactive AD
(Figure 2). Consistent results were obtained for the diffusion
rate constant (D/L2) which was for PEGs 282–590 Da
approximately twice as high in AD patients as in the control
subjects, whereas for PEG150 it was only 65% higher in AD
patients (Table 1).
The partition coefficient for AD patients was approxi-
mately half as large as in the control subjects for all PEG
molecules, except for PEG150, where it was about 60% of
that in the control subjects (Po0.0001 for all PEGs). We
compared all three groups of subjects; again, the result of
one-way analysis of variance test was significant (Po0.01)
and Bonferroni post hoc analyses were performed. The
partition coefficient was also significantly lower in patients
with active or inactive AD than in the control subjects for all
PEGs (Po0.05). There was no significant difference between
patients with active and inactive AD (Figure 2).
The calculated permeability coefficients were nearly the
same for both the AD patients and control subjects (Table 1).
The inter-individual differences in diffusion coefficient,
partition coefficient, rate constant for diffusion, and perme-
ability coefficient were considerable in both the AD patients
and the control subjects. For different PEG oligomers, the
observed range of the coefficient of variation in AD
patients was 49–73% for the diffusion coefficient, 44–77%
for the diffusion rate constant, 29–55% for the partition
coefficient, and 32–80% for permeability coefficient; in
control subjects, we found 58–66% for the diffusion
coefficient, 45–62% for the diffusion rate constant, 42–58%
for the partition coefficient, and 31–56% for permeability
coefficient.
DISCUSSION
This in vivo study assessed the penetration of PEGs ranging in
MW from 150 to 590 Da into the SC of AD patients and
control subjects. The skin-stripping method used enabled us
to estimate two penetration parameters, the effective diffusion
coefficient in the SC and the partition coefficient between SC
and vehicle from which the permeability coefficient could be
calculated.
The diffusion coefficient across SC was about twice as
high in AD patients as in the control subjects for all PEG
oligomers. The consistent results were obtained for the
diffusion rate constant, D/L2. There was no clear tendency
for an increase with state of disease (Figure 2). These findings
are in line with our parallel study in the same subjects, where
we found an increased diffusion coefficient and diffusion rate
constant for sodium lauryl sulfate in uninvolved skin of AD
patients compared to control subjects (Jakasa et al., 2006).
The higher diffusion of PEG we found in AD skin is consistent
with the in vitro findings in hairless mice: the penetration of
polydispersed PEG (PEG300, PEG600, and PEG1000)
through normal skin and skin damaged by acetone, sodium
lauryl sulfate, or tape stripping increased with the degree of
barrier disruption as measured by TEWL (Tsai et al., 2001,
2003).
With respect to the diffusion coefficient in the SC, different
mathematical functions have been proposed to describe the
effect of solute size (Kasting et al., 1987; Cleek and Bunge,
1993). In these functions, the diffusion coefficient decreases
exponentially with increasing molecular size and predict a
stronger effect of MW than the gradual decrease observed in
our study, where in the range of MW from 280 to 590, this
relation appeared to be linear (Figure 3). The experimentally
determined dependence of permeability coefficients upon
MW was less steep than predicted by Potts and Guy (1992)
algorithm (log Kp¼ –2.72þ0.71 log Kow0.0061MW)
(Figure 4). For the prediction, we assumed the constant value
of Kow of 1.6 for all MW (Hollander et al., 1989). This
assumption is supported by the similar values of the
partitioning coefficient we found for all PEG oligomers.
The results from our study are consistent with in vitro data
obtained for hydrophilic compounds, showing weaker
dependence of permeability coefficient on molecular size
then predicted by Potts & Guy algorithm (Mitragotri, 2003).
Recent in vitro study revealed that the impact of MW on the
skin permeability depends on the penetrant hydrophilicity,
showing that penetration of cyclosporin with MW41,000 Da
could be substantially increased by introduction of polar side
chains (Billich et al., 2005).
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Figure 2. Average apparent diffusion coefficient (D) and partition coefficient (K) of PEG150–590 Da in the SC of patients with active and inactive AD after
6 hours dermal exposure to PEG mixture. The results are shown as mean7SD.
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Not only the diffusion coefficient but also the partitioning
of PEGs into AD skin was different from that in the control
skin: the partition coefficient was twice as high in the control
subjects as in the AD patients. There was also no clear
tendency for a decrease with state of disease (Figure 2).
Decreased partitioning of PEGs into diseased skin might be
explained by the dryness of the AD skin: a smaller amount
of water will decrease the partitioning of hydrophilic PEGs
into the SC. In contrast to the diffusion coefficient,
the partition coefficient was similar for all PEG oligomers.
This was consistent with a similar octanol–water parti-
tion coefficient over a broad range of MWs (Hollander
et al., 1989).
The experimentally obtained permeability coefficients
were similar in both AD patients and control subjects.
Although AD patients showed increased diffusion coeffi-
cients, this increase was offset by a proportional decrease in
the partition coefficients in AD patients. The steady-state flux
will therefore be the same in both AD and normal skin;
however, the AD patients will elicit a shorter lag time for
transport of a chemical across the skin. For situations in
which the exposure ends before steady state is reached during
the exposure (the most common situation in real life), the flux
into the body from the skin will be higher for the AD skin
because D is larger. Although the total amount of PEG that
eventually goes into the body from the skin will be larger for
the control skin owing to higher partitioning, the rate that it
goes into the body will be larger for the AD person. With
respect to toxicity, the rate can be more important than the
total amount. If the rate is slow enough, the body might be
able to manage the chemical (i.e., metabolize it and
eliminate it fast enough relative to the rate at which it enters
the body).
Compounds which have such a low permeability like
PEGs, will probably have a low relevance for pharmaceutical
purposes. However, from a toxicological point of view, one
has to keep in mind that also larger molecules are able to
penetrate the skin, and as shown in this study this will be
even more pronounced when the skin is impaired. As skin
damaged mechanically, chemically or physiologically is not
uncommon, when evaluating the health risk associated with
skin exposure, penetration of higher MW compounds should
be considered.
To summarize, the skin of AD patients showed increased
diffusion coefficients for all PEGs when compared to control
subjects. This supports the hypothesis that skin barrier
function is altered even in skin that is visibly unaffected by
AD. Possible implications of the findings are that AD patients
might have a higher susceptibility for inflammation of the
uninvolved skin, which in turn will increase permeability,
resulting in a vicious circle. Additionally, in the design of new
drugs, also compounds with larger MW could be suitable for
therapeutic treatment.
MATERIALS AND METHODS
Study population
Twenty AD patients, 12 males and eight females, with a mean age of
29 years (range 18–54 years) and 20 healthy subjects, 11 males and
nine females, with a mean age of 32 years (range 18–55 years), all
Caucasians, participated in the study which was carried out in June
and July 2004.
The AD patients were recruited from the outpatients clinic of the
Academic Medical Center and diagnosed according to the Hanifin
and Rajka (1980) criteria. We excluded patients who had received
systemic therapy, such as corticosteroids and immunosuppressants,
or phototherapy in the past 2 years. Subjects with concomitant
ichthyosis vulgaris were also excluded. The test sites, both mid-volar
arms had been free of dermatitis for at least 3 months before the
experiment. The total eczema area and severity index (maximum 72
points) was assessed in the AD patients (Hanifin et al., 2001). The
severity of the disease was mild in all the patients and the median
eczema area and severity index was 1.7 (ranging from 0.2 to 22.8).
Twelve patients had active AD (pruritic lesions) and eight had
inactive AD (they had been free of dermatitis for at least 3 months,
showing only mild signs at the time – scars, scaling, lichenification,
or dry skin) on body parts other than the test sites. The control
subjects had no visible skin damage and no history of past or present
AD or other dermatological diseases.
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All the subjects completed the Erlangen questionnaire, from
which an atopy score was calculated (maximum 34 points; a score
X10 is considered as atopy) (Diepgen, 1991). AD patients and
control subjects had a score of 17.476.6 and 3.072.4 (mean7SD),
respectively.
The participants were not allowed to use soap, moisturizers, or any
other cosmetics or creams on the lower mid-volar arms for 48 hours
before and during the experiments. Written informed consent was
obtained from all the subjects before the experiment. The Medical
Ethics Committee of the Academic Medical Center, University of
Amsterdam, approved the experimental protocol. The study was
conducted according to the Declaration of Helsinki Principles.
Penetration experiment
The application mixture of PEGs was made by spiking 10 g of
polydispersed PEG600 (average MW¼ 600 Da, Sigma, The Nether-
lands) with 47.5 mg of monodispersed PEG150 (MW¼ 150.17 Da,
Sigma, The Netherlands), 50.1 mg of monodispersed PEG282
(MW¼ 282.34 Da, Acros Organics, New Jersey, NY), 102.9 mg of
monodispersed PEG326 (MW¼ 326.4 Da, PolyPure, Norway), and
199.1 mg of monodispersed PEG370 (MW¼ 370.4 Da, PolyPure,
Norway), to which 2 ml of water was added. Subjects were exposed
for 6 hours to the PEG application mixture (180 ml) on the mid-volar
arms using round patch test chambers (Finn Chamberss, 18 mm in
diameter, Epitest Ltd, Finland). These prevented evaporation of water
from the test site and this combined with excess PEG insured that the
exposure concentration remained constant during the exposure. The
TEWL was measured on application sites, before patch application,
after patch removal, and during the tape stripping procedure, using
an evaporimeter (VapoMeter SWL2 g, Delfin Technologies Ltd,
Kuopio, Finland). Twenty minutes prior the application, the subjects
rested with their sleeves rolled up in the examination room, where
the temperature was 20–221C and the relative humidity ranged
between 50 and 60%. After the removal of the patch containing PEG
mixture, a piece of dry cell tissue was gently pressed to the skin site
to remove the residue of PEG mixture. Templates of Scanpors tape
were fixed to the skin around the application spot to limit the tape
stripping to exposed area (18 mm in diameter). Ten minutes after the
end of exposure, the SC layers were sequentially removed with pre-
cut pieces of Diamond tape, 19 25 mm (Diamond Ultra Clear tape,
The Sellotapes Company, The Netherlands). The tape pieces were
consecutively applied to the test site and uniformly pressed with a
1 kg stainless-steel roller, which was moved 10 times in two
directions. The total removal of the SC was evidenced by the
glistening, redness of the skin and additionally by checking visually
that there was no SC present on the last obtained strips. We have also
observed that the TEWL became very high (4100 g m2 hour1).
Each individual strip was placed into a glass vial and stored at 201C
until analysis. The SC from a non-exposed site was harvested with
the adhesive system described above and served as negative control.
Analytical procedure
The gas chromatographic method for the determination of PEGs in
tape strips have been described in detail elsewhere (Jakasa et al.,
2004). Briefly, the method is based on extraction of PEGs from the
tape strips with methanol (J.T. Baker, The Netherlands) and
subsequent derivatization with pentafluoropropionic anhydride
(Fluka, The Netherlands) at 70751C for 30 minutes in dichloro-
methane (P.A., Merck, The Netherlands) and pyridine (Alltech, The
Netherlands).
For the analysis of proteins, we used modified method of Dreher
et al. (1998). Briefly, the remaining methanol solution containing
tape strip was evaporated. One milliliter of 1 M sodium hydroxide
(Merck, The Netherlands) was added to the strip and the vials were
shaken for 2 hours. The samples were left at room temperature
overnight and the next day they were shaken for 2 hours one more
time. One milliliter of 1 M hydrochloric acid (Merck, The Nether-
lands) was added to neutralize basic solution. The protein assay was
performed according to Bio-Rad DC protein microassay (Bio-Rad
Laboratories, Germany) using commercially available BSA for
standardization.
The concentration of PEGs on each strip was normalized for the
amount of proteins and expressed as mg of PEG/mg of protein.
Assuming an SC density of 1 g cm3 (Anderson and Cassidy, 1973)
and uniform distributions of SC on the tapes and proteins within the
SC (mg), the protein mass removed was converted to a volume,
enabling the depth of each strip in the SC (x). In our calculation of
the SC solute concentration, it was assumed that the protein
concentration in the SC was 1 mg/ml throughout the SC.
Data analysis
To estimate the penetration parameters, we used an approach based
on Fick’s second law of diffusion which applies to the non-steady
state condition (Crank, 1975), as described extensively elsewhere
(Pirot et al., 1997). In this method, two parameters, K and D/L2, are
determined by best-fit regression of the concentration of PEGs as a
function of relative SC depth (x/L) (Figure 1) to the following equation:
CðxÞ ¼ KCveh 1 x
L
 

X1
n¼1
2
np
KCvehsin
npx
L
 
exp
Dn2p2t
L2
 
; ð1Þ
where Cveh is the applied PEGs concentration (mg cm
3), C is the PEG
concentration (mg cm3) at depth (cm), K is the SC/water partition
coefficient, L is the total thickness of the SC (cm), D is the apparent
diffusion coefficient of PEGs through the pseudo-homogeneous SC
(cm2 hour1), D/L2 (hour1) is the diffusion rate constant, and t is the
exposure duration (hour). In deriving Equation 1, K and D/L2 are
assumed to be constant throughout the SC.
The permeability coefficient (Kp, cm hour
1) for each PEG
oligomer was calculated from the relationship Kp¼KD/L. The
first strip was not included in the regression analysis, as it contained
some PEG residues on the surface of the skin after the end of
exposure. All concentration data were weighted equally in the
regression analysis. Prism 4 (Graph Pad Software Inc., San Diego,
CA) and SPSS software were used (SPSS Inc., Chicago, IL) for curve
fitting and statistical calculations. Student’s t-test and one-way
analysis of variance with Bonferroni post-test were used for statistical
calculations and P-value o0.05 was considered significant.
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